Pioneering Medicines Director, DMPK Project Lead / Project Rep

Cambridge, MA, United States

What if... We could harness the power of Flagship's scientific platforms and create novel treatment options that benefit more patients, sooner?

Pioneering Medicines, an initiative of Flagship Pioneering, is building a world-class biopharmaceutical R&D capability focused on conceiving and developing life-changing treatments for patients by harnessing the power of Flagship's scientific platforms and applying those innovative approaches to serious diseases with unmet medical need. Unique to Pioneering Medicines' approach is the opportunity to combine platforms to create truly novel and potentially transformative treatments.

About Flagship Pioneering:

Flagship Pioneering conceives, creates, resources, and develops first-in-category life science platform companies to transform human health and sustainability. Since its founding in 2000, the firm has originated and fostered the development of more than 100 scientific ventures, resulting in over $34 billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents.

Position Summary:

We are seeking a skilled and self-motivated individual Director Project Lead / Rep to provide DMPK Project support across our diverse drug discovery portfolio targeting a broad range of disease areas and therapeutic modalities. The qualified candidate will apply knowledge and technical expertise in in vitro and in vivo ADME and PK to drive project team strategy. The incumbent will work collaboratively with discovery and development teams to establish optimal lead candidate characteristics, develop ADME/PK strategies, and execute preclinical studies intended to characterize potential drug candidates. We are seeking individual who is analytical, goal-oriented, independent, swift, and committed to maintaining the highest scientific and ethical standards. Strong communication skills and comfort working in a dynamic, fast-paced, cross-functional team environment are highly desirable.

Key Responsibilities:

Represent the DMPK function on cross-functional discovery teams and provide technical and scientific expertise for ADME profiling and interpretation of the data.

Define strategy for in vitro/in vivo DMPK and DDI risk assessment for drug candidates.

Strategically design and lead ADME/PK studies, critically analyze and interpret data, identify issues, and help overcome technical challenges.

Coordinate and interact with matrix project team members for planning and executing DMPK-related activities.

Collaborate with PK/PD modelers to establish PK/PD correlations and guide preclinical study design.

Contribute to the selection of preclinical tox species and toxicokinetic plan to support IND.

Support human dose projections based on preclinical data to guide candidate selection.

Author ADME/DMPK sections of regulatory documents (e.g., IND/IB).

Contribute to the development of functional processes and procedures focused on CRO interactions and organizational efficiency.

Conduct scientific presentations to senior management, project teams, and internal/external collaborators.

Provide operational oversight for quality and performance of DMPK activities, including interactions with CROs and external project support.

Contribute to the selection and qualification of CROs and vendors.

Closely interact with key internal stakeholders and Flagship ecosystem companies

Basic Qualifications: Ph.D. in pharmaceutical science, biochemistry, or related scientific discipline with

7+ years or MS/BS with 10+years of relevant experience

5+ years experience leading representing DMPK function on project teams, particularly in discovery and early development is required.

Extensive knowledge of drug metabolism, PK, and relevant analytical techniques is required.

Strong understanding of small molecule drug discovery workflow is required; understanding of biologics/novel modalities is desirable.

Hands on experience conducting, troubleshooting, and summarizing in vitro and in vivo ADME/DMPK studies is required.

Familiarity with regulatory guidelines and requirements related to DMPK in drug development is desirable.

Demonstrated DMPK skills through high quality peer-reviewed publications is desirable.

Experience in outsourcing and external oversight of nonclinical DMPK/ADME studies is desirable.

Attention to detail and quality are critical to success.

Excellent communication skills including interpersonal skills and data presentation skills.

Demonstrated ability to adapt to a fast-paced and dynamic work environment.

Demonstrated ability to successfully work in cross-functional teams with an emphasis on teamwork, collaboration, and communication within team and across the department.

Forward thinking mindset with demonstrated ability to manage multiple projects and identify and resolve issues.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies : Flagship Pioneering and its affiliated Flagship Lab companies (collectively, "FSP") do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering's internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

#LI-TD1